Related Experiment Video
Updated: May 17, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine
Amber M Holbrook1, Jason K Baxter, Hendrée E Jones
1Department of Pediatrics, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Aims:
To characterize infections and compare obstetric outcomes in opioid-dependent pregnant women who participated in a randomized clinical trial comparing agonist medications, methadone and buprenorphine.
Design:
Incidence of infections was identified as part of the screening medical assessment. As part of a planned secondary analysis, analysis of variance and polytomous logistic regressions were conducted on obstetric outcome variables using treatment randomization condition (maternal maintenance with either methadone or buprenorphine) as the predictor variable, controlling for differences between study sites.
Setting:
Six United States sites and one European site that provided comprehensive treatment to opioid-dependent pregnant women.
Participants:
Pregnant opioid-dependent women (n = 131) who delivered while participating in the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study.
Measurements:
Obstetric, infectious and other maternal medical complications captured by medical records, physical examination, blood tests and self-report. Neonatal medical complications captured by medical records.
Findings:
Hepatitis C was the most common infection (32.3%), followed by hepatitis B (7.6%) and chlamydia (6.1%) among participants at study enrollment. Maternal methadone versus buprenorphine maintenance was associated with a higher incidence of preterm labor (P = 0.04) and a significantly higher percentage of signs of respiratory distress in neonates at delivery (P = 0.05). Other medical and obstetric complications were infrequent in the total sample, as well as in both methadone and buprenorphine conditions.
Conclusions:
Buprenorphine appears to have an acceptable safety profile for use during pregnancy.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Development of the Oral Microbiota
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Intrauterine Drug Delivery Systems
